Monthly cost of canafenib/encofenib

Encorafenib is a targeted drug used to treat certain types of melanoma, especially those with BRAF V600 mutations. Its mechanism of action is to inhibit the activity of BRAF protein, thereby slowing down the growth and spread of tumor cells. Cost is undoubtedly an important consideration for patients wishing to be treated with the drug.

The recommended dosage of canafenib varies depending on the treatment regimen: for melanoma, the recommended dose is 450 mg per day, or six 75 mg capsules; for metastatic colorectal cancer, it is 300 mg per day, or four 75 mg capsules. These treatment options are often combined with other medications to increase efficacy and slow disease progression.

However, the original drug of canafenib has not yet been launched in the Chinese market, so the specific cost information is not yet clear. In the international market, especially in Europe, the price of canafenib is relatively high. For example, the price of a 42-pellet 75mg package may exceed RMB 10,000 per box, while the larger 75mg 168-pellet package may cost more than RMB 40,000. These prices are affected by a variety of factors, particularly exchange rate fluctuations and changes in market demand.

Depending on the patient's medication plan, if taken once a day, based on a 30-day course of treatment, the monthly drug cost may be tens of thousands of RMB. In addition, the patient's specific condition will influence actual medication use. For example, doctors may adjust the medication regimen based on the patient's response and disease progression, which may require increasing or decreasing the dose. If it is used in combination with other drugs, the overall treatment cost will increase accordingly. Therefore, it is best for patients to have a detailed discussion with their doctor before taking medication to understand the best medication plan for them.